Show simple item record

dc.contributor.authorCollier, N
dc.contributor.authorAllan, Donald
dc.contributor.authorDiaz Pesantes, F
dc.contributor.authorSheridan, Linda
dc.contributor.authorAllan, Ernest
dc.date.accessioned2017-10-18T21:11:19Z
dc.date.available2017-10-18T21:11:19Z
dc.date.issued2017-09-22
dc.identifier.citationSystemic photodynamic therapy in folliculitis decalvans. 2017, Clin Exp Dermatolen
dc.identifier.issn1365-2230
dc.identifier.pmid28940572
dc.identifier.doi10.1111/ced.13238
dc.identifier.urihttp://hdl.handle.net/10541/620594
dc.description.abstractFolliculitis decalvans (FD) is classified as a primary neutrophilic cicatricial alopecia, and is estimated to account for approximately 10% of all cases of primary cicatricial alopecia. The role of dysfunctional immune activity and the presence of bacteria, particularly Staphylococcus aureus, appear pivotal. We describe a 26-year-old man with a 4-year history of FD that was recalcitrant to numerous systemic and topical therapies, whose disease was virtually cleared during a follow-up of 25 months following a course of treatment with systemic photodynamic therapy (PDT) using ultraviolet light (100-140 J/cm(2) ) with porfimer sodium 1 mg/kg as monotherapy. This is the first report of the use of systemic PDT as a treatment for FD. Systemic PDT has potent antibacterial effects with little or no resistance. In addition, systemic PDT provides local immunomodulation and improved scar healing. Significant adverse effects following systemic PDT with appropriate aftercare are rare. This case demonstrates that systemic PDT is a useful therapy option in the treatment of recalcitrant FD.
dc.language.isoenen
dc.rightsArchived with thanks to Clinical and experimental dermatologyen
dc.titleSystemic photodynamic therapy in folliculitis decalvans.en
dc.typeArticleen
dc.contributor.departmentDermatology Centre, University of Manchester, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Manchesteren
dc.identifier.journalClinical and Experimental Dermatologyen
html.description.abstractFolliculitis decalvans (FD) is classified as a primary neutrophilic cicatricial alopecia, and is estimated to account for approximately 10% of all cases of primary cicatricial alopecia. The role of dysfunctional immune activity and the presence of bacteria, particularly Staphylococcus aureus, appear pivotal. We describe a 26-year-old man with a 4-year history of FD that was recalcitrant to numerous systemic and topical therapies, whose disease was virtually cleared during a follow-up of 25 months following a course of treatment with systemic photodynamic therapy (PDT) using ultraviolet light (100-140 J/cm(2) ) with porfimer sodium 1 mg/kg as monotherapy. This is the first report of the use of systemic PDT as a treatment for FD. Systemic PDT has potent antibacterial effects with little or no resistance. In addition, systemic PDT provides local immunomodulation and improved scar healing. Significant adverse effects following systemic PDT with appropriate aftercare are rare. This case demonstrates that systemic PDT is a useful therapy option in the treatment of recalcitrant FD.


This item appears in the following Collection(s)

Show simple item record